(4-(Pyridin-2-ylcarbamoyl)phenyl)boronic acid
- CAS
- 850568-25-1
- Formula
- C12H11BN2O3
- MW
- 242.04 g/mol
VQ-035463
Impurity reference standards
Acalabrutinib impurities & reference standards
Characterised Acalabrutinib impurities, degradation products and related compounds for analytical method development, validation, QC release and regulatory filings.
34reference materials
COAHPLC · NMR · MS on request
Parent API: Acalabrutinib WS
1420477-60-6 · C26H23N7O2
![(S)-1-Bromo-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-8-amine](/media/pack/s-1-bromo-3-pyrrolidin-2-ylimidazo15-apyrazin-8-amine.svg?v=3)
(S)-1-Bromo-3-(pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-8-amine
- CAS
- 2097168-73-3
- Formula
- C10H12BrN5
- MW
- 282.14 g/mol
VQ-035476
![(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate chemical structure](/media/structures/DLXYYJDQLZHBNU-ZDUSSCGKSA-N.svg)
(S)-Benzyl 2-(8-amino-1-bromoimidazo[1,5-a]pyrazin-3-yl)pyrrolidine-1-carboxylate
- CAS
- 1420478-88-1
- Formula
- C18H18BrN5O2
- MW
- 416.3 g/mol
VQ-024122
![4-(8-Amino-3-(4-(but-2-ynamido)butanoyl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide chemical structure](/media/structures/XZAATUBTUPPERZ-UHFFFAOYSA-N.svg)
4-(8-Amino-3-(4-(but-2-ynamido)butanoyl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide
- CAS
- 2230757-47-6
- Formula
- C26H23N7O3
- MW
- 481.5 g/mol
VQ-021393
![4-[8-Amino-3-(3,4-dihydro-2H-pyrrol-5-yl)imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide chemical structure](/media/structures/PYLYCDADEDOFBZ-UHFFFAOYSA-N.svg)
4-[8-Amino-3-(3,4-dihydro-2H-pyrrol-5-yl)imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide
- CAS
- 2230757-49-8
- Formula
- C22H19N7O
- MW
- 397.4 g/mol
VQ-021392
Acalabrutinib R Isomer Intermediate Impurity
- CAS
- 2198380-46-8
- Formula
- C18H18BrN5O2
- MW
- 416.3 g/mol
VQ-021391
N-(Pyridin-2-yl)-2-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
- CAS
- 2180911-32-2
- Formula
- C18H20BNO4
- MW
- 325.2 g/mol
VQ-024121
N-2-Pyridinyl-3-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzamide
- CAS
- 2180911-29-7
- Formula
- C18H21BN2O3
- MW
- 324.2 g/mol
VQ-028993
![N4,N4'-Di(pyridin-2-yl)-[1,1'-biphenyl]-4,4'-dicarboxamide chemical structure](/media/structures/KNOBFXXGBACXDE-UHFFFAOYSA-N.svg)
N4,N4'-Di(pyridin-2-yl)-[1,1'-biphenyl]-4,4'-dicarboxamide
- CAS
- 723260-09-1
- Formula
- C24H18N4O2
- MW
- 394.4 g/mol
VQ-024123
FAQs — Acalabrutinib impurities
Which Acalabrutinib impurities do you supply?
We list 34 Acalabrutinib-related reference materials, including process impurities, degradation products and related compounds. Each is supplied with a COA, and characterisation data (HPLC, 1H-NMR, MS, IR) can be provided on request.
What are Acalabrutinib impurity standards used for?
They are used for analytical method development and validation, impurity identification and quantification, forced-degradation and stability studies, and to support ANDA, DMF and other regulatory submissions under ICH Q3A/Q3B (and ICH M7 for mutagenic impurities).
Can you synthesise a Acalabrutinib impurity that is not listed?
Yes. Our custom synthesis service can prepare and characterise unlisted impurities, metabolites and labelled analogues from milligram to gram scale. Share the structure or name and required quantity for a quotation.
Request Acalabrutinib impurity standards
We reply within one business day with price, pack options, lead time and documentation.